Cite

HARVARD Citation

    Davies, A. et al. (n.d.). Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial. Lung cancer. pp. S70-. [Online]. 
  
Back to record